Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us


Global Radiopharmaceuticals Market- Pervasiveness of Chronic Diseases and Consequent Diagnosis to Stimulate Demand

Press release Description

Albany, New York, July 27, 2018: In the current scenario, there has been an interminable proliferation of cancer & cardiovascular ailments globally. The aforementioned prevalence of diseases is creating a scintillating demand for radiopharmaceuticals across the globe. Other factors fostering the demand include surging awareness pertaining to its positive effects, rising preferences for SPECT and PET scans, and developments in radiotracers are some of the key facets determining growth of radiopharmaceuticals market

In addition to this, there has been a drift in rising preferences for radiopharmaceuticals, which is further likely to support the growth of the global market. On the other hand, uncompromising regulatory guidelines, incoherent supply of radioisotopes, and a shorter half-life of radiopharmaceuticals act as major roadblocks hampering the growth. These insights are derived from a new report, titled “Radiopharmaceuticals Market– Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2024,” recently added to the exhaustive repository of Market Research Reports Search Engine (MRRSE).

Radiopharmaceuticals Market- Hospitals to be at the Vanguard of Demand

By end-user, hospitals play a pivotal role followed by other end users such as ambulatory surgical centers, diagnostic centers, & others (universities, research labs, and pathology labs). The report provides a detailed outlook of the market size and projection in terms of US$ Mn for the respective forecast timeline. The radiopharmaceutical products are recording mounting applications across areas of oncology, cardiology, neurology, nephrology, gastroenterology, immunology and others. Oncology segment is the most dominant one among others, which emphasizes application of different radioisotopes in a bid to treat cancers and overcome the adverse effects of therapeutics.

Radiopharmaceutical Market: Scope of the Report

This report focuses on the size of radiopharmaceutical market & analyzes the market scenario, both present and future. Rising incidences of various epidemics, advent of new sources for radioisotope production, and increasing demand for nuclear medicine are propelling the demand for radiopharmaceuticals. Rising cases of cancer and cardiovascular diseases, heightening awareness about effective use of radiopharmaceuticals, and elevating demand for SPECT and PET scans are some of the key market influencers shaping the global radiopharmaceutical market during the forecast period.

The radiopharmaceutical market report encompasses a detailed executive summary, including a market snapshot providing information pertinent to various segments. Moreover, it also provides information and data analysis of the global market with regard to segments based on radioisotopes, source, end-user, and regions. The report also features a qualitative analysis of market drivers and restraints along with prime opportunities, which have been included in the market overview section. Moreover, the SWOT analysis included in the report helps the market players understand major areas like strengths, weaknesses, opportunities and threats which are of paramount importance.

The report also profiles key players functioning in the global market based on various aspects such as company overview, product portfolio, financial overview, business strategies, and major developments. Some of the key players included in this report based on their foothold amid the competition include Advanced Accelerator Applications (AAA), Eckert & Ziegler, GE Healthcare, IBA Radiopharma Solutions, Lantheus Holdings, Inc., Mallinckrodt PLC, Nordion, Inc., Siemens Healthineers, and Positron Corporation.

Browse Full Global Radiopharmaceuticals Market Report with TOC :

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.


State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559